Satriyo PB - Search Results

1

G2/M Checkpoint Modulation: Insights from miRNA Profiles in FAM and Breast Cancer.

Haryana SM, Ardiansyah SA, Noficandra H, Wardana T, Sesotyosari SL, Arfira FR, Satriyo PB, Setiasari DW, Heriyanto DS. Haryana SM, et al. Among authors: satriyo pb. Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2661-2668. doi: 10.31557/APJCP.2024.25.8.2661. Asian Pac J Cancer Prev. 2024. PMID: 39205563 Free PMC article.

2

N-phenyl pyrazoline derivative inhibits cell aggressiveness and enhances paclitaxel sensitivity of triple negative breast cancer cells.

Satriyo PB, Mustofa M, Wahyuningsih TD, Damayanti E, Wiraswati HL, Satria D, Bashari MH, Sholikhah EN. Satriyo PB, et al. Sci Rep. 2024 Jun 8;14(1):13200. doi: 10.1038/s41598-024-63778-2. Sci Rep. 2024. PMID: 38851778 Free PMC article.

3

Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study.

Wiraswati HL, Bashari MH, Alfarafisa NM, Ma'ruf IF, Sholikhah EN, Wahyuningsih TD, Satriyo PB, Mustofa M, Satria D, Damayanti E. Wiraswati HL, et al. Among authors: satriyo pb. Adv Appl Bioinform Chem. 2024 Feb 27;17:33-46. doi: 10.2147/AABC.S452281. eCollection 2024. Adv Appl Bioinform Chem. 2024. PMID: 38435441 Free PMC article.

4

A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells.

Mustofa, Satriyo PB, Suma AAT, Waskitha SSW, Wahyuningsih TD, Sholikhah EN. Mustofa, et al. Among authors: satriyo pb. Drug Des Devel Ther. 2022 Jul 20;16:2325-2339. doi: 10.2147/DDDT.S350913. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35899233 Free PMC article.

5

Bruton's tyrosine kinase (BTK) mediates resistance to EGFR inhibition in non-small-cell lung carcinoma.

Yeh CT, Chen TT, Satriyo PB, Wang CH, Wu ATH, Chao TY, Lee KY, Hsiao M, Wang LS, Kuo KT. Yeh CT, et al. Among authors: satriyo pb. Oncogenesis. 2021 Jul 27;10(7):56. doi: 10.1038/s41389-021-00345-8. Oncogenesis. 2021. PMID: 34315851 Free PMC article.

6

4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.

Satriyo PB, Su CM, Ong JR, Huang WC, Fong IH, Lin CC, Aryandono T, Haryana SM, Deng L, Huang CC, Tzeng YM, Chao TY, Liu HW, Yeh CT. Satriyo PB, et al. Toxicol Appl Pharmacol. 2021 Jul 1;422:115493. doi: 10.1016/j.taap.2021.115493. Epub 2021 Mar 13. Toxicol Appl Pharmacol. 2021. PMID: 33727089

7

Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.

Satriyo PB, Bamodu OA, Chen JH, Aryandono T, Haryana SM, Yeh CT, Chao TY. Satriyo PB, et al. J Clin Med. 2019 Jan 27;8(2):148. doi: 10.3390/jcm8020148. J Clin Med. 2019. PMID: 30691241 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters